For the year ending 2025-12-31, SKYE has $28,313,633 in assets. $8,289,458 in debts. $5,882,498 in cash and cash equivalents.
| Balance Sheets | 2025-12-31 | |||
|---|---|---|---|---|
| Cash and cash equivalents | 5,882,498 | |||
| Short-term investments | 19,854,723 | |||
| Prepaid expenses | 504,890 | |||
| Other current assets | 852,036 | |||
| Total current assets | 27,094,147 | |||
| Property and equipment, net | 898,930 | |||
| Operating lease right-of-use asset | 266,646 | |||
| Other assets | 53,910 | |||
| Total assets | 28,313,633 | |||
| Accounts payable | 2,033,431 | |||
| Accrued payroll liabilities | 1,269,474 | |||
| Other current liabilities | 2,643,840 | |||
| Estimate for accrued legal contingencies and related expenses | 2,069,067 | |||
| Operating lease liability, current portion | 189,647 | |||
| Total current liabilities | 8,205,459 | |||
| Operating lease liability, net of current portion | 83,999 | |||
| Total liabilities | 8,289,458 | |||
| Common stock, 0.001 par value 100,000,000 shares authorized at december31, 2025 and 2024, respectively 33,378,139 and 30,974,559 shares issued and outstanding at december31, 2025 and 2024, respectively | 33,379 | |||
| Additional paid-in-capital | 206,865,282 | |||
| Accumulated deficit | -186,874,486 | |||
| Total stockholders equity | 20,024,175 | |||
| Total liabilities and stockholders equity | 28,313,633 | |||
Skye Bioscience, Inc. (SKYE)
Skye Bioscience, Inc. (SKYE)